Clinical Trial Update: Comparison of Exparel to Marcaine in Post-Surgical Analgesia in Bariatrics [Phase 4]

View source ↗

Summary

Clinical trial comparing Exparel to Marcaine for post-surgical analgesia in bariatric patients was withdrawn (Phase 4).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Pain

Drugs mentioned

• Exparel (liposomal bupivacaine)
• Marcaine (bupivacaine)

Snippet

Sponsor: Kettering Health Network | Conditions: Post Operative Pain | Phase 4 | Status: WITHDRAWN